Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC150759 |
| Upstream (Parents) |
|---|
| (<<) CUX2 → LOC150759 |
| (<<) DUSP4 → LOC150759 |
| (<<) BHLHE41 → LOC150759 |
| (<<) CBR3 → LOC150759 |
| (<<) GABBR1 → LOC150759 |
| (<<) ANKRD36B → LOC150759 |
| (<<) MGMT → LOC150759 |
| Downstream (Children) |
|---|
| LOC150759 → CXCL5 (>>) |
| LOC150759 → PIGR (>>) |
| LOC150759 → PEX5L (>>) |
| LOC150759 → GRID2 (>>) |
| LOC150759 → NCR1 (>>) |
| LOC150759 → ITGB3 (>>) |
| LOC150759 → NPC1 (>>) |
| LOC150759 → ADCYAP1R1 (>>) |
| LOC150759 → ROBO3 (>>) |
| LOC150759 → SMNP (>>) |
| LOC150759 → CACNG1 (>>) |
| LOC150759 → P2RX1 (>>) |
| LOC150759 → HTN1 (>>) |
| LOC150759 → ARHGEF10 (>>) |
| LOC150759 → ANKRD36B (>>) |
| LOC150759 → ST6GALNAC2 (>>) |
| LOC150759 → ZNF507 (>>) |
